Literature DB >> 9096434

Gender differences in irritable bowel symptoms.

W G Thompson1.   

Abstract

OBJECTIVE: Some data suggest that the Manning criteria for diagnosis of the irritable bowel syndrome (IBS) are less reliable in men. This research aims to detect gender differences in the prevalence of individual diagnostic criteria in IBS patients.
DESIGN: One hundred and fifty-six IBS patients (26 males, 130 females) were asked about their bowel symptoms including the Manning and Rome criteria.
RESULTS: In the IBS group, 90.4% fulfilled the Manning criteria (91.5% females, 84.6% males), and 68.6% the Rome criteria (70.8% females and 57.7% males). The three pain-related criteria (pain relieved by defecation, pain followed by change in stool frequency or stool consistency) were similarly present in males and females. However, mucus, feeling of incomplete evacuation, and distension were found in 86 (66.2%), 78 (60%) and 72 (55.4%) of the women, compared to 10 (38%), 7 (26.9%) and 9 (36.9%) of the men (P<0.009, P<0.002 and P=0.053, respectively). Scybala, which are among the Rome criteria, were also less prevalent in males (7.7% vs. 29.2% (P<0.03)).
CONCLUSION: Among IBS patients, pain-related Manning symptoms are similar in men and women, but mucus, incomplete evacuation, distension and scybala are less common in men. Less reporting of these symptoms by men may account for reduced clinical reliability of the Manning or Rome criteria in men and their apparent low prevalence of IBS.

Entities:  

Mesh:

Year:  1997        PMID: 9096434     DOI: 10.1097/00042737-199703000-00015

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  18 in total

1.  Colonic motor function in humans is not affected by gender.

Authors:  E E Soffer; K Kongara; J P Achkar; J Gannon
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

2.  Tegaserod and IBS: a perfect match?

Authors:  W Grant Thompson
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 3.  Expert commentary--bloating, distension, and the irritable bowel syndrome.

Authors:  Richard Lea; Peter J Whorwell
Journal:  MedGenMed       Date:  2005-01-10

4.  Appropriateness of outpatient gastrointestinal endoscopy in a non-academic hospital.

Authors:  João Mangualde; Marie I Cremers; Ana M Vieira; Ricardo Freire; Elia Gamito; Cristina Lobato; Ana L Alves; Fátima Augusto; Ana P Oliveira
Journal:  World J Gastrointest Endosc       Date:  2011-10-16

Review 5.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 6.  Irritable bowel syndrome.

Authors:  S M Turner; J E Stewart; J J Alexopulos; J S Hill
Journal:  Curr Rev Pain       Date:  2000

Review 7.  Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants.

Authors:  W G Paterson; W G Thompson; S J Vanner; T R Faloon; W W Rosser; R W Birtwhistle; J L Morse; T A Touzel
Journal:  CMAJ       Date:  1999-07-27       Impact factor: 8.262

Review 8.  Bloating and functional gastro-intestinal disorders: where are we and where are we going?

Authors:  Paola Iovino; Cristina Bucci; Fabrizio Tremolaterra; Antonella Santonicola; Giuseppe Chiarioni
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 9.  New treatments for irritable bowel syndrome in women.

Authors:  Mopelola A Adeyemo; Lin Chang
Journal:  Womens Health (Lond)       Date:  2008-11

10.  Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.

Authors:  Michael Camilleri; Andrea Shin; Irene Busciglio; Paula Carlson; Andres Acosta; Adil E Bharucha; Duane Burton; Jesse Lamsam; Alan Lueke; Leslie J Donato; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-10       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.